623 related articles for article (PubMed ID: 30209206)
21. A matter of background: DNA repair pathways as a possible cause for the sparse distribution of CRISPR-Cas systems in bacteria.
Bernheim A; Bikard D; Touchon M; Rocha EPC
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180088. PubMed ID: 30905287
[TBL] [Abstract][Full Text] [Related]
22. Gene editing in clinical isolates of Candida parapsilosis using CRISPR/Cas9.
Lombardi L; Turner SA; Zhao F; Butler G
Sci Rep; 2017 Aug; 7(1):8051. PubMed ID: 28808289
[TBL] [Abstract][Full Text] [Related]
23. A Cloning-Free Method for CRISPR/Cas9-Mediated Genome Editing in Fission Yeast.
Zhang XR; He JB; Wang YZ; Du LL
G3 (Bethesda); 2018 May; 8(6):2067-2077. PubMed ID: 29703785
[TBL] [Abstract][Full Text] [Related]
24. Expanding the plant genome editing toolbox with recently developed CRISPR-Cas systems.
Wada N; Osakabe K; Osakabe Y
Plant Physiol; 2022 Mar; 188(4):1825-1837. PubMed ID: 35099553
[TBL] [Abstract][Full Text] [Related]
25. Good guide, bad guide: spacer sequence-dependent cleavage efficiency of Cas12a.
Creutzburg SCA; Wu WY; Mohanraju P; Swartjes T; Alkan F; Gorodkin J; Staals RHJ; van der Oost J
Nucleic Acids Res; 2020 Apr; 48(6):3228-3243. PubMed ID: 31989168
[TBL] [Abstract][Full Text] [Related]
26. CRISPR-Cas: biology, mechanisms and relevance.
Hille F; Charpentier E
Philos Trans R Soc Lond B Biol Sci; 2016 Nov; 371(1707):. PubMed ID: 27672148
[TBL] [Abstract][Full Text] [Related]
27. CRISPR-Cas9 Direct Fusions for Improved Genome Editing via Enhanced Homologous Recombination.
Tabassum T; Pietrogrande G; Healy M; Wolvetang EJ
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834150
[TBL] [Abstract][Full Text] [Related]
28. Diversity and evolution of class 2 CRISPR-Cas systems.
Shmakov S; Smargon A; Scott D; Cox D; Pyzocha N; Yan W; Abudayyeh OO; Gootenberg JS; Makarova KS; Wolf YI; Severinov K; Zhang F; Koonin EV
Nat Rev Microbiol; 2017 Mar; 15(3):169-182. PubMed ID: 28111461
[TBL] [Abstract][Full Text] [Related]
29. Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides.
Rivera-Torres N; Banas K; Bialk P; Bloh KM; Kmiec EB
PLoS One; 2017; 12(1):e0169350. PubMed ID: 28052104
[TBL] [Abstract][Full Text] [Related]
30. In planta gene targeting can be enhanced by the use of CRISPR/Cas12a.
Wolter F; Puchta H
Plant J; 2019 Dec; 100(5):1083-1094. PubMed ID: 31381206
[TBL] [Abstract][Full Text] [Related]
31. Exploiting CRISPR-Cas immune systems for genome editing in bacteria.
Barrangou R; van Pijkeren JP
Curr Opin Biotechnol; 2016 Feb; 37():61-68. PubMed ID: 26629846
[TBL] [Abstract][Full Text] [Related]
32. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
[TBL] [Abstract][Full Text] [Related]
33. CRISPR: From Prokaryotic Immune Systems to Plant Genome Editing Tools.
Bandyopadhyay A; Mazumdar S; Yin X; Quick WP
Adv Exp Med Biol; 2017; 1016():101-120. PubMed ID: 29130156
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency.
Canny MD; Moatti N; Wan LCK; Fradet-Turcotte A; Krasner D; Mateos-Gomez PA; Zimmermann M; Orthwein A; Juang YC; Zhang W; Noordermeer SM; Seclen E; Wilson MD; Vorobyov A; Munro M; Ernst A; Ng TF; Cho T; Cannon PM; Sidhu SS; Sicheri F; Durocher D
Nat Biotechnol; 2018 Jan; 36(1):95-102. PubMed ID: 29176614
[TBL] [Abstract][Full Text] [Related]
35. The CRISPR-Cas system for plant genome editing: advances and opportunities.
Kumar V; Jain M
J Exp Bot; 2015 Jan; 66(1):47-57. PubMed ID: 25371501
[TBL] [Abstract][Full Text] [Related]
36. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms.
Javed MR; Sadaf M; Ahmed T; Jamil A; Nawaz M; Abbas H; Ijaz A
Curr Microbiol; 2018 Dec; 75(12):1675-1683. PubMed ID: 30078067
[TBL] [Abstract][Full Text] [Related]
37. Genome Editing During Development Using the CRISPR-Cas Technology.
Arzate-Mejía RG; Licona-Limón P; Recillas-Targa F
Methods Mol Biol; 2018; 1752():177-190. PubMed ID: 29564772
[TBL] [Abstract][Full Text] [Related]
38. CRISPR-Cas: New Tools for Genetic Manipulations from Bacterial Immunity Systems.
Jiang W; Marraffini LA
Annu Rev Microbiol; 2015; 69():209-28. PubMed ID: 26209264
[TBL] [Abstract][Full Text] [Related]
39. Design and Validation of CRISPR/Cas9 Systems for Targeted Gene Modification in Induced Pluripotent Stem Cells.
Lee CM; Zhu H; Davis TH; Deshmukh H; Bao G
Methods Mol Biol; 2017; 1498():3-21. PubMed ID: 27709565
[TBL] [Abstract][Full Text] [Related]
40. Genome editing by natural and engineered CRISPR-associated nucleases.
Wu WY; Lebbink JHG; Kanaar R; Geijsen N; van der Oost J
Nat Chem Biol; 2018 Jul; 14(7):642-651. PubMed ID: 29915237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
